Investment Firm
Overview
Diotheris develops bacterial therapies of the human skin and mucosal microbiome intended to protect against pathogenic bacteria.
Jul 07, 2020
Seed
Highlights
N/A
Location
Social
Participant Investors
1
Investor Name |
---|
InnoBio Fund |
Diotheris raised an undisclosed amount on 2020-07-07 in Seed Round
Diotheris develops bacterial therapies of the human skin and mucosal microbiome intended to protect against pathogenic bacteria.
Company Funding History
1
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Jul 07, 2020 | Seed Round - Diotheris | 1 | - | undefined |
Recent Activity
There is no recent news or activity for this profile.